dedic
professor
koji
nakanishi
occas
birthday
honor
receiv
tetrahedron
prize
abstractth
proteolyt
process
polyprotein
proteas
sever
acut
respiratori
syndrom
coronaviru
essenti
viral
propag
seri
tripeptid
bunsatur
ester
ketomethylen
isoster
includ
synthes
assay
target
proteas
though
inact
ic
lm
ketomethylen
isoster
tripeptid
bunsatur
ester
contain
phenylalanin
residu
show
modest
inhibitori
activ
ic
lm
pheph
dipeptid
inhibitor
design
basi
comput
model
enzymeinhibitor
complex
potent
inhibitor
inhibit
constant
lm
obtain
condens
pheph
dipeptid
bunsatur
ester
dimethylamino
cinnam
acid
cellbas
assay
also
indic
nontox
antisar
agent
ec
valu
lm
sever
acut
respiratori
syndrom
sar
first
occur
guandong
china
novemb
spread
mani
countri
ill
caus
infect
novel
human
coronaviru
sarscov
fatal
rate
sarscov
infect
rather
high
estim
month
nearli
live
claim
natur
sourc
sarscov
unclear
though
studi
molecular
evolut
sarscov
indic
viru
may
emerg
wild
anim
present
efficaci
therapi
sar
avail
therefor
search
effect
antivir
sarscov
current
interest
sarscov
belong
coronavirida
famili
includ
porcin
transmiss
gastroenter
viru
tgev
human
coronaviru
hcov
mous
hepat
viru
bovin
coronaviru
infecti
bronchiti
viru
sarscov
positivestrand
rna
viru
encod
two
replicas
polyprotein
extens
proteolyt
process
nonstructur
polyprotein
requir
provid
function
protein
viral
propag
process
mediat
primarili
main
proteas
pro
also
known
dimer
chymotrypsinlik
proteas
pro
activ
site
sarscov
proteas
contain
constitut
catalyt
dyad
cystein
function
common
nucleophil
proteolyt
process
proteas
cleav
less
conserv
site
sequenc
leu
met
phe
gln
ser
ala
gli
glutamin
residu
invari
occupi
site
proteas
essenti
propag
viru
thu
serv
key
target
discoveri
antisar
drug
far
inhibitor
valid
vitro
proteas
assay
proteas
inhibitor
includ
c
symmetr
peptidomimet
compound
zincconjug
compound
bifunct
aryl
boron
acid
quinolinecarboxyl
deriv
thiophenecarboxyl
phthalhydrazidesubstitut
ketoglutamin
analog
ketomethyl
isoster
tripeptideconjug
ester
compound
scheme
potent
inhibitor
human
rhinoviru
hrv
proteas
also
cystein
proteas
mediat
matur
cleavag
replicas
polyprotein
structur
incorpor
clactam
moieti
mimic
amido
side
chain
glutamin
residu
improv
cell
membran
permeabl
phenylalanin
residu
replac
methylen
isoster
bear
substitu
previou
pharmacophor
model
analog
structur
tgev
main
proteinas
indic
partial
fit
put
bind
pocket
sarscov
proteas
moieti
conjug
ester
may
function
acceptor
thu
propos
model
design
inhibitor
sarscov
proteas
paper
describ
synthesi
inhibit
sarscov
proteas
antisar
activ
relat
ketomethylen
isoster
peptidomimet
bunsatur
ester
although
turn
inact
bunsatur
ester
found
potent
antivir
agent
k
lm
ec
lm
basi
previous
report
method
improv
synthesi
accomplish
use
natur
glutam
acid
serin
valin
build
block
scheme
approach
dianion
alkyl
nboc
glutam
acid
dimethyl
ester
step
ii
occur
highli
stereoselect
manner
give
exclus
product
yield
reduct
cyano
group
catalyt
hydrogen
follow
situ
cycliz
afford
clactam
yield
ester
group
effect
reduc
nabh
presenc
licl
alcohol
product
oxid
aldehyd
parikhdo
method
subsequ
condens
wittig
reagent
emmon
method
give
conjug
ester
yield
hand
epoxyest
r
chiral
obtain
l
lserin
via
diazot
bromid
substitut
base
treatment
assist
cubr
grignard
reagent
h
mgbr
react
regioselect
manner
give
alcohol
product
activ
correspond
triflat
n
reaction
triflat
valinederiv
malon
follow
remov
tertbutyloxycarbonyl
boc
group
acid
condit
provid
desir
ketomethylen
isoster
catalyt
hydrogen
presenc
ditertbutyl
carbon
furnish
direct
convers
benzyloxycarbonyl
cbz
group
boc
group
ketomethylen
isoster
known
suscept
epimer
alkalin
condit
case
hydrolysi
realiz
use
equiv
lioh
h
without
complic
epimer
acid
product
treat
allyl
iodid
presenc
cs
co
give
allyl
ester
singl
product
oxid
condens
aqueou
hno
gave
acid
correspond
acyl
chlorid
react
remov
boc
group
give
amid
presenc
nmethylmorpholin
allyl
group
smoothli
remov
catalysi
pd
pph
result
acid
coupl
amin
deriv
culmin
synthesi
spectroscop
properti
prepar
sampl
agreement
report
investig
structureact
relationship
also
appli
combinatori
approach
synthes
ketomethylen
isoster
eg
variou
r
r
substitu
ntermin
site
addit
correspond
tripeptidomimet
bunsatur
ester
prepar
procedur
gener
use
peptid
synthesi
use
phenylalanin
replac
residu
lactamglutam
seri
ketomethylen
isoster
tripeptidomimet
bunsatur
ester
also
synthes
comparison
studi
accord
previous
describ
fluorometr
method
conjug
ester
seri
subject
inhibit
assay
sarscov
proteas
initi
veloc
inhibit
reaction
use
nm
sarscov
proteas
lm
fluorogen
substrat
plot
differ
inhibitor
concentr
obtain
ic
valu
comparison
tabl
tripeptidomimet
bunsatur
ester
seri
tend
activ
correspond
ketomethylen
isoster
seri
although
predict
good
inhibitor
sar
proteas
turn
inact
concentr
lm
enzymat
assay
result
agreement
cellbas
assay
indic
inact
sar
cov
howev
structureact
relationship
studi
analog
indic
inhibitori
activ
improv
replac
lactamglutamin
isoster
l
lphenylalanin
exampl
compound
phenyl
group
replac
lactam
moieti
show
better
inhibitori
activ
ic
lm
analog
lbd
ic
lm
observ
enhanc
inhibitori
activ
compound
phenylalanin
replac
posit
prompt
us
conduct
comput
model
enzym
complex
inhibitor
target
structur
use
model
deduc
complex
structur
sarscov
proteas
mutant
hexapeptid
substrat
serglyvalthrphegln
accordingli
apoenzym
bchain
contain
appli
molecular
simul
design
inhibitor
comput
dock
bind
properli
activ
site
sarscov
proteas
fig
though
posit
fluorophenyl
side
chain
site
lactam
moieti
fit
site
proteas
without
interf
proper
disposit
termin
conjug
ester
group
site
unlik
effect
bind
rhinoviru
proteas
conjug
ester
prevent
suitabl
interact
sarscov
figur
structur
yellow
model
structur
sarscov
pro
superimpos
cocryst
structur
hexapeptid
serglyvalthrphegln
magenta
fragment
close
contact
distanc
comput
mgltool
van
der
waal
radiu
factor
residu
contribut
major
steric
effect
model
label
red
figur
model
complex
sarscov
proteas
inhibitor
proteas
shown
white
line
model
wherea
catalyt
dyad
site
compound
highlight
atomcolor
ballandstick
model
stick
compound
color
green
individu
atom
display
gray
carbon
blue
nitrogen
red
oxygen
yellow
sulfur
hexapeptid
serglyvalthrphegln
white
stick
model
overlaid
comparison
display
structur
compound
elect
dock
cluster
lowest
bind
free
energi
potenti
hydrogenbond
interact
compound
residu
bind
pocket
shown
green
broken
line
proteas
therebi
forc
adopt
posit
outsid
pocket
defin
possibl
steric
effect
also
exert
fluorophenyl
group
pocket
isoxazoyl
moieti
hydrophob
residu
pocket
contrast
compound
two
phenyl
group
residu
fit
respect
pocket
sarscov
proteas
fig
overlay
serglyvalthrphegln
hexapeptid
upon
show
conform
similar
simul
model
also
reveal
key
hydrogen
bond
residu
activ
site
proteas
note
isoxazolyl
moieti
adopt
conform
differ
thu
accommod
favor
hydrogen
bond
gin
pocket
bind
mode
thu
contribut
better
inhibitori
activ
ic
lm
ic
lm
residu
move
pocket
moieti
conjug
ester
may
occupi
site
exert
interact
howev
conjug
ester
still
unreach
render
michael
reaction
coval
cs
bond
format
molecular
model
reveal
compound
seri
show
better
inhibitori
activ
compound
seri
place
phenylalanin
residu
pocket
sarscov
proteas
surmis
pheph
dipeptid
contain
conjug
amido
moieti
ntermin
compound
virtual
pseudoc
symmetri
may
exhibit
greater
inhibitori
activ
strategi
parallel
synthesi
microtit
plate
appli
construct
analog
thu
pheph
dipeptidyl
bunsatur
ester
prepar
amid
nbocphenylalanin
ethyl
treat
hcl
remov
boc
group
result
amin
react
librari
bunsatur
carboxyl
acid
give
analog
subject
without
isol
inhibit
assay
sarscov
proteas
basi
preliminari
result
assay
promis
inhibitor
candid
select
scaleup
synthesi
ic
valu
inhibit
constant
k
pure
sampl
measur
valid
activ
tabl
fortun
find
dipeptidomimet
bunsatur
ester
bear
cinnamyl
moieti
ntermin
show
good
inhibitori
activ
sarscov
proteas
among
compound
deriv
pheph
dipeptid
bunsatur
ester
dimethylamino
cinnam
acid
potent
inhibitor
ic
valu
lm
k
valu
lm
doubl
reciproc
plot
initi
rate
versu
substrat
concentr
indic
compound
competit
inhibitor
repres
exampl
inhibit
sarscov
proteas
shown
figur
comput
model
complex
sarscov
proteas
fig
show
phenyl
group
occupi
pocket
respect
conjug
dimethylamino
cinnamyl
group
dispos
rather
rigid
coplanar
structur
ntermin
render
effect
hydrogen
bond
residu
enzym
comparison
compound
also
synthes
subject
inhibit
assay
dipeptid
deriv
contain
clactam
moieti
site
lieu
phenyl
group
tripeptid
deriv
homolog
dipeptid
introduct
addit
valin
residu
dimer
peptid
conjug
ester
prepar
use
diacid
eg
succin
acid
smalic
acid
tartar
acid
core
structur
link
phenylalanin
bunsatur
ester
compound
deriv
pheph
dipeptid
methylenedioxi
cinnam
acid
show
ic
valu
lm
k
valu
lm
assay
indic
none
activ
sarscov
proteas
antivir
activ
evalu
protect
cytopathogen
effect
cpe
vero
cell
inact
activ
antisar
agent
concentr
lm
even
potent
antisar
activ
lm
antisar
compound
evalu
multipl
concentr
deduc
concentr
inhibit
host
growth
cc
inhibitori
concentr
viru
replic
ec
enzymelink
immunosorb
assay
elisa
none
toxic
growth
host
cell
lm
highest
concentr
use
assay
ec
valu
compound
deduc
elisa
measur
viral
spike
protein
express
lm
tabl
thu
ratio
cc
ec
select
index
si
compound
high
antivir
activ
confirm
western
blot
assay
use
antispik
protein
monoclon
antibodi
fig
signific
suppress
viral
express
proteas
also
observ
treatment
concentr
lm
data
shown
although
real
reason
smaller
ec
k
unclear
specul
environ
physic
state
proteas
may
differ
sarsinfect
cell
recombin
proteas
use
cellfre
assay
tri
assay
condit
use
low
concentr
nm
sar
proteas
extend
reaction
time
h
show
sign
slow
inhibit
due
irrevers
bond
format
compound
assay
prolong
period
infeas
due
deplet
substrat
uncertain
whether
actual
inhibitor
bind
may
tighter
slow
conform
chang
hand
inhibitor
may
partial
block
process
polyprotein
matur
previou
studi
suggest
dimer
proteas
activ
form
studi
use
cellfre
system
also
suggest
nand
ctermin
tag
form
autoproteolyz
autoproteolyt
process
suscept
proteas
inhibitor
furthermor
proteas
also
proteolyz
polyprotein
tran
matur
cellfre
studi
therefor
suggest
presenc
multipl
form
proteolyt
activ
physic
state
proteas
reactiv
sarsinfect
cell
like
even
complic
like
proteas
hiv
proteas
synthes
part
polyprotein
autoproteolyz
proteas
matur
thought
dimer
hiv
proteas
take
place
enzym
still
form
polyprotein
synthes
migrat
membran
bud
site
locat
time
autoproteolysi
crucial
hiv
viral
infect
littl
known
physic
state
enzym
reactiv
proteas
sarsinfect
cell
thu
imposs
surmis
time
ratelimit
target
proteas
inhibitor
sar
infect
studi
need
understand
regul
proteolyt
activ
physic
state
enzym
present
sarsinfect
cell
control
sar
viru
use
proteas
inhibitor
devis
improv
method
prepar
effici
manner
although
analog
bear
lactamglutamin
residu
show
inhibitori
activ
sarscov
proteas
relat
conjug
ester
found
exhibit
improv
activ
pheph
dipeptid
inhibitor
design
basi
comput
model
enzymeinhibitor
complex
potent
inhibitor
inhibit
constant
lm
obtain
condens
pheph
dipeptid
bunsatur
ester
dimethylamino
cinnam
acid
cellbas
assay
indic
nontox
antisar
agent
ec
valu
lm
addit
valinomycin
ec
lm
knowledg
compound
repres
potent
antisar
agent
known
date
comput
studi
structureact
relationship
show
hydrogen
bond
main
chain
side
chain
crucial
inhibitori
potenc
interact
support
model
complex
sarscov
proteas
inhibitor
current
investig
cocryst
structur
give
insight
propos
complex
mode
design
new
antisar
compound
melt
point
uncorrect
h
nmr
spectra
record
mhz
reaction
requir
dri
condit
carri
inert
atmospher
use
standard
techniqu
reagent
solvent
reagent
grade
use
without
purif
unless
otherwis
specifi
thf
distil
sodium
benzophenon
ketyl
n
tripeptid
ketomethylen
isoster
lbd
prepar
procedur
similar
peptid
bunsatur
ester
prepar
similar
procedur
compound
prepar
accord
previous
describ
procedur
allyl
tertbutoxycarbonyl
lithium
hydroxid
mmol
ml
aqueou
solut
ad
solut
methyl
ester
g
mmol
meoh
ml
mixtur
stir
h
n
hcl
ml
ad
figur
western
blot
analysi
inhibitori
effect
compound
sarscov
spike
protein
synthesi
mixtur
extract
etoac
ml
combin
organ
layer
dri
mgso
concentr
reduc
pressur
provid
crude
carboxyl
acid
g
crude
product
dissolv
dmf
ml
treat
allyl
iodid
ml
mmol
presenc
cs
co
g
mmol
h
mixtur
dilut
water
ml
extract
etoac
ml
combin
organ
layer
wash
water
ml
dri
na
concentr
reduc
pressur
residu
purifi
flash
column
chromatographi
etoachexan
afford
allyl
ester
mg
colorless
oil
solut
hcl
ml
ad
solut
allyl
ester
mg
mmol
ml
room
temperatur
mixtur
stir
h
concentr
reduc
pressur
give
crude
aminium
salt
materi
dissolv
ch
cl
ml
cool
ml
mmol
chlorid
mg
mmol
ad
sequenti
mixtur
remov
ice
bath
stir
h
dilut
ch
cl
ml
mixtur
wash
aqueou
citric
acid
ml
brine
ml
organ
phase
dri
na
concentr
purifi
flash
column
chromatographi
etoac
hexan
give
desir
product
mg
pheph
dipeptid
bunsatur
ester
mg
mmol
treat
hcl
procedur
similar
give
correspond
aminium
salt
subject
coupl
reaction
appropri
substitut
cinnam
acid
mmol
dmf
ml
promot
hbtu
mmol
ipr
net
mmol
procedur
similar
afford
dipeptid
conjug
ester
yield
propenyl
ethyl
tertbutoxycarbonyl
treat
hcl
remov
boc
group
result
amin
react
succin
acid
presenc
edci
hobt
procedur
similar
give
yield
n
n
bi
propenyl
use
malic
acid
lieu
succin
acid
compound
prepar
procedur
similar
n
n
propenyl
use
tartar
acid
lieu
succin
acid
compound
prepar
procedur
similar
fluorometr
assay
util
determin
inhibit
constant
prepar
sampl
briefli
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
use
substrat
enhanc
fluoresc
due
cleavag
substrat
catalyz
proteas
monitor
nm
excit
nm
ic
valu
individu
sampl
measur
reaction
mixtur
contain
nm
sarscov
proteas
lm
fluorogen
substrat
mm
bistri
ph
enzym
stock
solut
kept
mm
trishcl
ph
contain
mm
nacl
mm
edta
mm
dtt
plu
mm
bme
ad
assay
solut
k
measur
perform
two
fix
inhibitor
concentr
variou
substrat
concentr
vero
cell
well
cultur
plate
fb
dmem
supplement
fb
cultur
medium
remov
incub
cell
reach
confluenc
solut
dmem
fb
contain
compound
test
place
three
well
three
well
contain
cell
dmem
fb
use
cpeposit
control
cell
incub
co
incub
h
inocul
sarscov
hk
dose
tcid
well
cytopath
morpholog
cell
examin
use
invert
microscop
h
infect
vero
cell
grown
dmem
supplement
l
lglutamin
nonessenti
amino
acid
fb
cell
cultur
cm
flask
incub
humidifi
co
incub
cell
later
seed
cellsml
onto
plate
left
overnight
cytotox
studi
mt
assay
perform
use
cell
titer
nonradioact
cell
prolifer
assay
kit
promega
co
madison
wi
usa
determin
popul
live
cell
assay
measur
amount
formazan
produc
metabol
convers
reagent
inner
salt
mt
dehydrogenas
present
mitochondria
metabol
activ
cell
directli
proport
number
live
cell
briefli
incub
test
compound
vari
concentr
day
cultur
medium
replac
mtspm
dmem
incub
h
absorb
sampl
measur
plate
reader
nm
data
express
percentag
control
cell
cultur
absenc
test
compound
conclus
incub
sarsvirusinfect
vero
cell
rins
pb
fix
icecold
methanolaceton
solut
min
room
temperatur
rins
three
time
pb
cell
block
skim
milk
pb
min
room
temperatur
incub
h
dilut
monoclon
antibodi
ascet
fluid
spike
protein
sarscov
sampl
wash
three
chang
pbst
buffer
twice
fresh
chang
pb
buffer
room
temperatur
follow
incub
hrplabel
goat
antimous
igg
min
room
temperatur
plate
rins
pb
contain
tween
incub
substrat
solut
contain
ophenylenediamin
dihydrochlorid
citrat
buffer
ph
hydrogen
peroxid
ad
well
plate
cover
gentli
shaken
room
temperatur
min
reaction
stop
addit
sulfur
acid
n
plate
read
immedi
nm
ec
valu
test
agent
extrapol
linear
regress
plot
agent
concentr
versu
od
sarscovinfect
vero
cell
treat
compound
vari
concentr
h
lyse
lysi
buffer
min
cell
debri
spun
cell
lysat
harvest
electrophoresi
western
blot
assay
sdspage
hybondc
extra
membran
amersham
pharmacia
result
membran
block
skim
milk
pb
min
room
temperatur
treat
dilut
antispik
protein
monoclon
antibodi
chemiconmab
h
room
temperatur
membran
rins
use
two
chang
pbst
buffer
wash
min
twice
min
fresh
pb
buffer
room
temperatur
follow
treatment
horseradish
peroxidaselabel
goat
antimous
igg
min
dilut
h
membran
wash
mix
enhanc
chemiluminesc
detect
reagent
ad
protein
side
membran
blot
place
protein
side
film
cassett
visual
level
protein
express
dock
experi
conduct
use
autodock
lamarckian
genet
algorithm
lga
crystal
structur
pdb
code
complex
mutat
sarscov
proteas
hexapeptid
substrat
serglyvalthrphegln
refin
use
cy
residu
apo
chain
b
dimer
simul
structur
inhibitori
compound
built
cach
fujitsu
japan
refin
perform
optim
geometri
calcul
mechan
use
augment
paramet
store
pdb
format
mgltool
mgl
scripp
institut
use
structur
prepar
paramet
creation
meet
input
requir
autodock
briefli
essenti
hydrogen
atom
ad
structur
model
pro
follow
assign
kollman
unit
atom
charg
solvat
paramet
compound
molecul
assign
gasteigermarsili
charg
merg
nonpolar
h
atom
defin
torsion
autogrid
tool
autodock
appli
comput
energi
grid
xyz
direct
space
variou
type
compound
atom
grip
map
center
activ
site
dock
experi
compound
kept
flexibl
except
ring
amid
bond
protein
rigid
soli
local
search
method
lga
appli
gener
avail
conform
compound
structur
within
activ
site
conform
search
conduct
util
quaternion
step
compound
structur
energi
evalu
pose
select
gener
per
run
plausibl
dock
mode
elect
collect
bind
free
energi
cluster
simul
pose
structur
within
root
mean
squar
deviat
select
abund
cluster
highest
affin
energi
conserv
hydrogen
bond
interact
observ
crystal
complex
consid
addit
factor
elect
bind
mode
pictur
final
simul
dock
mode
gener
mgltool
